| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 09/05/2006 | US7101672 detection and/or identification of genetic polymorphism associated with human disease and infection; viral and bacterial strain identification |
| 09/05/2006 | US7101671 Method and equipment to monitor nucleic acid hybridization on a DNA chip using four-dimensional parameters |
| 09/05/2006 | US7101669 Enzyme-based regeneration of surface-attached nucleic acids |
| 09/05/2006 | US7101666 Involvement of the BDNF gene in mood disorders |
| 09/05/2006 | US7101661 Apparatus for active programmable matrix devices |
| 09/05/2006 | US7101559 Immunomodulatory protein and useful embodiments thereof |
| 09/05/2006 | US7101556 Preparation and usage of plasmodium fusion antigen |
| 09/05/2006 | CA1341511C Method of contolling plant pests |
| 09/02/2006 | CA2496690A1 A novel c. elegans p21-activated kinase (pak) gene and associated loss-of-function phenotypes that facilitate screening for small molecule modulators of pak activity in the nematode, caenorhabditis elegans |
| 08/31/2006 | WO2006091871A1 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases |
| 08/31/2006 | WO2006091470A2 Improved halohydrin dehalogenases and related polynucleotides |
| 08/31/2006 | WO2006091231A2 Biosynthetic polypeptides utilizing non-naturally encoded amino acids |
| 08/31/2006 | WO2006090906A1 NOVEL METHOD FOR OVERCOMING RNAi-RESISTANT STRAIN OF VIRUS |
| 08/31/2006 | WO2006074162A3 Primer generation rolling circle amplification |
| 08/31/2006 | WO2006051552A3 Directed evolution and selection using in vitro compartmentalization |
| 08/31/2006 | WO2006047683A3 Antisense antiviral compound and method for treating influenza viral infection |
| 08/31/2006 | WO2006028655A3 Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer |
| 08/31/2006 | WO2006026322A3 Aspartic proteinase protein gene non-coding regulatory elements for use in plants |
| 08/31/2006 | WO2006018572A3 Method for labeling and purifying nucleic acids of interest present in a biological sample to be treated in a single reaction vessel |
| 08/31/2006 | WO2005076732A3 Peptide-pna chimera targeting inducible nitric oxide synthase |
| 08/31/2006 | WO2005056020A8 Nf-kb oligonucleotide decoy molecules |
| 08/31/2006 | WO2005047307A3 Il-18 binding proteins |
| 08/31/2006 | WO2005027631A3 Proteins which confer biotic and abiotic stress resistance in plants |
| 08/31/2006 | WO2004033657A3 Heat shock protein binding fragments of cd91, and uses thereof |
| 08/31/2006 | US20060195947 Variant polypeptides having enhanced ketoreductase activity and/or thermostability for use in the stereospecific reduction of ketones; non-naturally occurring ketoreductas polypeptide capable of converting ethyl 4-chloroacetoacetate to ethyl (S)-4-chloro-3-hydroxybutyrate |
| 08/31/2006 | US20060195943 plant size, vegetative growth, organ number, plant architecture and/or biomass that are altered with respect to wild type plants; food product |
| 08/31/2006 | US20060195942 Expressed sequence tags for use in targeting and isolation of genes for plant protection and improvement |
| 08/31/2006 | US20060195941 Nucleic acid molecules and other molecules associated with plants |
| 08/31/2006 | US20060195939 Delta-8 desaturase and its use in making polyunsaturated fatty acids |
| 08/31/2006 | US20060195938 Polynucleotides encoding insect acetyl coenzyme-A carboxylase and uses thereof |
| 08/31/2006 | US20060195935 Selection of host cells expressing protein at high levels |
| 08/31/2006 | US20060195932 Nucleic acid molecules and other molecules associated with the carbon assimilation pathway |
| 08/31/2006 | US20060195922 Soybean cultivar 4817034 |
| 08/31/2006 | US20060195920 Chalcone synthase dihydroflavonol 4-reductase and leucoanthocyanidine from clover, medic ryegrass or fescue |
| 08/31/2006 | US20060195915 mesencephalic astrocyte-derived neurotrophic factor polypeptide; shown to protect the survival of embryonic mesencephalic dopaminergic neurons in culture |
| 08/31/2006 | US20060194959 Sequence-determined DNA fragments encoding SRF-type transcription factors |
| 08/31/2006 | US20060194958 Sequence-determined DNA fragments encoding AN1-like zinc finger proteins |
| 08/31/2006 | US20060194952 Enhancing the circulating half-life of antibody-based fusion proteins |
| 08/31/2006 | US20060194951 Polynucleotides encoding interferon gamma polypeptides |
| 08/31/2006 | US20060194751 Streptococcus pyogenes antigens |
| 08/31/2006 | US20060194735 Extending the shelf life of Therapeutic protein X; nucleic acids and vectors containing them; kits; treating, preventing, or ameliorating diseases, disorders or conditions |
| 08/31/2006 | US20060194314 Novel Bt toxin receptors from lepidopteran insects and methods of use |
| 08/31/2006 | US20060194304 Kit comprising sodium chloride, potassium chloride, guanidinium chloride, sodium perchlorate or other chaotropic salt; and a nonionic detergent of Triton, NP40, Tween, or Syperonic, or MOPS buffer; endotoxin-free; purification, centrifuging, chromatography, filtration; gene therapy |
| 08/31/2006 | US20060194295 Novel, esterase, fungus capable of producing the same and method for producing the same |
| 08/31/2006 | US20060194292 Contains insulin-like growth factor-I, insulin-like growth factor binding protein 3 and integrin-binding domain of vitronectin ; wound healing; surgical implant, prosthesis, scaffold, wound or burn dressing |
| 08/31/2006 | US20060194291 Comprising human immunoglobulin g1 fc region, which mediates antibody-dependent cell-mediated cytotoxicity in presence of effector cells more effectively; binds fc gamma receptor iii with better affinity |
| 08/31/2006 | US20060194290 Polypeptide variants with altered effector function |
| 08/31/2006 | US20060194289 Method of production of recombinant proteins in eukaryote cells |
| 08/31/2006 | US20060194288 Nucleic acid molecules encoding endonucleases and methods of use thereof |
| 08/31/2006 | US20060194287 Chemokine-binding protein and methods of use |
| 08/31/2006 | US20060194286 Apo-2LI and Apo-3 polypeptides |
| 08/31/2006 | US20060194285 Biological production of clavulanic acid and related compounds |
| 08/31/2006 | US20060194284 Recombinant co-expression of vitamin K epoxide reductase subunit 1 to improve vitamin K dependent protein expression |
| 08/31/2006 | US20060194283 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/31/2006 | US20060194282 Contains at least one mutation that reduces or eliminates the ability of the fluorescent protein to oligomerize; determining the pH of a sample, presence of an enzyme, and activity of an enzyme by variation of fluorescence; kits |
| 08/31/2006 | US20060194280 Methods for refolding of recombinant antibodies |
| 08/31/2006 | US20060194277 Method for producing target proteins by deleting or amplifyingibpa and/or ibpb gene coding for inclusion body-associated proteins |
| 08/31/2006 | US20060194276 Specificity grafting of a murine antibody onto a human framework |
| 08/31/2006 | US20060194275 Transporter and ion channels |
| 08/31/2006 | US20060194265 Novel therapeutic targets in cancer |
| 08/31/2006 | US20060194258 Polypeptide array synthesis |
| 08/31/2006 | US20060194257 MECP2E1 gene |
| 08/31/2006 | US20060194253 A transfected cell line and a method using the same for the high throughput screening for inhibitors of the t-type calcium channel alpha-1h |
| 08/31/2006 | US20060194250 Cancer diagnostic method based upon DNA methylation differences |
| 08/31/2006 | US20060194241 Lactobacillus specific probes |
| 08/31/2006 | US20060194240 Compositions and methods of detecting an analyte by using a nucleic acid hybridization switch probe |
| 08/31/2006 | US20060194239 Mitochondrial complex I mutations in parkinson's disease and aging |
| 08/31/2006 | US20060194235 HLJ1 gene expression |
| 08/31/2006 | US20060194233 Ligand of the protein "beacon" |
| 08/31/2006 | US20060194222 Triplex probe compositions and methods for polynucleotide detection |
| 08/31/2006 | US20060194219 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/31/2006 | US20060194218 Inducible fluorescence assay |
| 08/31/2006 | US20060194214 Methods for assembly of high fidelity synthetic polynucleotides |
| 08/31/2006 | US20060194213 Synthesis of 3'-, or 5'-, or internal methacrylamido-modified oligonucleotides |
| 08/31/2006 | US20060194210 Novel therapeutic targets in cancer |
| 08/31/2006 | US20060194204 Gene expressed in prostate cancer, methods and use thereof |
| 08/31/2006 | US20060194196 Novel surface protein (hbsag) variant of the hepatitis B virus |
| 08/31/2006 | US20060193872 Recombinant vesicular stomatitis virus vaccines for viral hemorrhagic fevers |
| 08/31/2006 | US20060193870 Compositions and methods for the therapy and diagnosis of colon cancer |
| 08/31/2006 | US20060193868 graphitic nanotubes substituted with chemical moieties or upon which certain cyclic compounds are adsorbed; complex structures comprised of such functionalized fibrils linked to one another; introducing functional groups onto the surface of such fibrils |
| 08/31/2006 | US20060193866 H pylori antigens |
| 08/31/2006 | US20060193863 Compositions and methods for diagnosing and treating prostate cancer |
| 08/31/2006 | US20060193861 Tumor necrosis factor receptors 6 alpha & 6 beta |
| 08/31/2006 | US20060193859 Methods of Treatment Using Antibodies to Neutrokine-alpha |
| 08/31/2006 | US20060193858 Full-lenth, isolated polypeptide comprising a polypeptide sequence of human SRC-like adaptor protein |
| 08/31/2006 | US20060193856 Aglycosyl anti-CD154 (CD40 ligand) antibodies and uses thereof |
| 08/31/2006 | US20060193848 Mammalian tumor susceptibility genes and their uses |
| 08/31/2006 | US20060193821 Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeutics |
| 08/31/2006 | CA2598823A1 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases |
| 08/31/2006 | CA2569381A1 Biosynthetic polypeptides utilizing non-naturally encoded amino acids |
| 08/30/2006 | EP1696035A2 Improved bacillus host cell |
| 08/30/2006 | EP1696030A1 TIE ligand homologues |
| 08/30/2006 | EP1696029A1 TIE ligand homologues |
| 08/30/2006 | EP1696026A1 Method of concentrating and purifying nucleic acid and apparatus therefor |
| 08/30/2006 | EP1695979A2 Gapped 2' modified oligonucleotides |
| 08/30/2006 | EP1695978A1 Nucleic acid ligands |
| 08/30/2006 | EP1694864A2 Compositions and methods for the diagnosis and treatment of tumor |
| 08/30/2006 | EP1694863A2 Chromosome 5 genetic variants related to dyslexia |
| 08/30/2006 | EP1694858A1 Method for detecting pathogenic mycobacteria in clinical specimens |
| 08/30/2006 | EP1694855A2 Oligonucleotides and methods for detection of west nile virus |